Home / Inspections / 707713

FDA Inspection 707713 — Roche Molecular Systems, Inc.

Roche Molecular Systems, Inc. — FEI 2243471

The FDA completed an inspection of Roche Molecular Systems, Inc. on January 27, 2011 in Branchburg, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 27, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Branchburg, NJ (United States)

Facility

Other inspections at this facility

  • 1323692 (NAI Fri Jun 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1224711 (VAI Fri Dec 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1100926 (NAI Wed Jul 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027092 (NAI Mon Jul 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1020421 (VAI Wed Jul 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources